| Literature DB >> 6796685 |
T K Schaaf, J S Bindra, J F Eggler, J J Plattner, A J Nelson, M R Johnson, J W Constantine, H J Hess, W Elger.
Abstract
In an effort to develop tissue-selective prostaglandin analogues resistant to the metabolic inactivating pathways of the natural materials, hybrid compounds modified both at C-1 with a sulfonimide moiety and in the n-amylcarbinol side chain with substituted phenoxy groups were synthesized and evaluated in a variety of in vitro models. Several of these analogues exhibited potent, tissue-selective, uterine stimulant activity, a finding subsequently confirmed in clinical studies with one member of this series, N-(methanesulfonyl)-16-phenoxy-omega-tetranor-PGE2-carboxamide (CP-34089/ZK-57671, sulprostone).Entities:
Mesh：
Substances：
Year: 1981 PMID： 6796685 DOI： 10.1021/jm00143a018
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446